166 related articles for article (PubMed ID: 33058810)
1. Meta-Analysis Comparing Culprit-Only Versus Complete Multivessel Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction.
Ullah W; Zahid S; Nadeem N; Gowda S; Munir S; Saleem S; Alraies MC; Alam M; Fischman DL
Am J Cardiol; 2021 Jan; 139():34-39. PubMed ID: 33058810
[TBL] [Abstract][Full Text] [Related]
2. Optimal Revascularization Strategy in Non-ST-Segment-Elevation Myocardial Infarction With Multivessel Coronary Artery Disease: Culprit-Only Versus One-Stage Versus Multistage Revascularization.
Kim MC; Hyun JY; Ahn Y; Bae S; Hyun DY; Cho KH; Sim DS; Hong YJ; Kim JH; Jeong MH; Kim HS; Gwon HC; Seong IW; Hwang KK; Chae SC; Hur SH; Cha KS; Oh SK
J Am Heart Assoc; 2020 Aug; 9(15):e016575. PubMed ID: 32750302
[TBL] [Abstract][Full Text] [Related]
3. What is the optimal approach to a non- culprit stenosis after ST-elevation myocardial infarction - Conservative therapy or upfront revascularization? An updated meta-analysis of randomized trials.
Anantha Narayanan M; Reddy YN; Sundaram V; Reddy YN; Baskaran J; Agnihotri K; Badheka A; Patel N; Deshmukh A
Int J Cardiol; 2016 Aug; 216():18-24. PubMed ID: 27135152
[TBL] [Abstract][Full Text] [Related]
4. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
[TBL] [Abstract][Full Text] [Related]
5. Complete revascularization versus culprit-only revascularization in ST-segment elevation myocardial infarction and multivessel disease patients undergoing primary percutaneous coronary intervention: A meta-analysis and trial sequential analysis.
Wang CH; Zhang SY; Jin XF
Int J Cardiol; 2017 Feb; 228():844-852. PubMed ID: 27907885
[TBL] [Abstract][Full Text] [Related]
6. Culprit-lesion only versus complete multivessel percutaneous intervention in ST-elevation myocardial infarction: A systematic review and meta-analysis of randomized trials.
Villablanca PA; Briceno DF; Massera D; Hlinomaz O; Lombardo M; Bortnick AE; Menegus MA; Pyo RT; Garcia MJ; Mookadam F; Ramakrishna H; Wiley J; Faggioni M; Dangas GD
Int J Cardiol; 2016 Oct; 220():251-9. PubMed ID: 27390938
[TBL] [Abstract][Full Text] [Related]
7. Complete vs Culprit-Lesion-Only Revascularization for ST-Segment Elevation Myocardial Infarction: A Systematic Review and Meta-analysis.
Bainey KR; Engstrøm T; Smits PC; Gershlick AH; James SK; Storey RF; Wood DA; Mehran R; Cairns JA; Mehta SR
JAMA Cardiol; 2020 Aug; 5(8):881-888. PubMed ID: 32432651
[TBL] [Abstract][Full Text] [Related]
8. Timing of Staged Nonculprit Artery Revascularization in Patients With ST-Segment Elevation Myocardial Infarction: COMPLETE Trial.
Wood DA; Cairns JA; Wang J; Mehran R; Storey RF; Nguyen H; Meeks B; Kunadian V; Tanguay JF; Kim HH; Cheema A; Dehghani P; Natarajan MK; Jolly SS; Amerena J; Keltai M; James S; Hlinomaz O; Niemela K; AlHabib K; Lewis BS; Nguyen M; Sarma J; Dzavik V; Della Siega A; Mehta SR;
J Am Coll Cardiol; 2019 Dec; 74(22):2713-2723. PubMed ID: 31779786
[TBL] [Abstract][Full Text] [Related]
9. Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry.
Galvão Braga C; Cid-Álvarez AB; Redondo Diéguez A; Trillo-Nouche R; Álvarez Álvarez B; López Otero D; Ocaranza Sánchez R; Gestal Romaní S; González Ferreiro R; González-Juanatey JR
Rev Esp Cardiol (Engl Ed); 2017 Jun; 70(6):425-432. PubMed ID: 27825718
[TBL] [Abstract][Full Text] [Related]
10. Meta-Analysis of Culprit-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
Bangalore S; Toklu B; Stone GW
Am J Cardiol; 2018 Mar; 121(5):529-536. PubMed ID: 29304995
[TBL] [Abstract][Full Text] [Related]
11. Revascularization Strategies in Patients With STEMI: Culprit-Only vs Multivessel Revascularization Using Percutaneous Coronary Intervention.
Alsadat N; Hyun K; D'Souza M; Chew D; Weaver J; Juergens C; Kritharides L; Hammett C; Brieger D
J Invasive Cardiol; 2019 Nov; 31(11):314-318. PubMed ID: 31303602
[TBL] [Abstract][Full Text] [Related]
12. Staged complete revascularization or culprit-only percutaneous coronary intervention for multivessel coronary artery disease in patients with ST-segment elevation myocardial infarction and diabetes.
Cui K; Lyu S; Liu H; Song X; Yuan F; Xu F; Zhang M; Wang W; Zhang M; Zhang D; Tian J
Cardiovasc Diabetol; 2019 Sep; 18(1):119. PubMed ID: 31530274
[TBL] [Abstract][Full Text] [Related]
13. Culprit versus multivessel coronary intervention in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
Vaidya SR; Qamar A; Arora S; Devarapally SR; Kondur A; Kaul P
Coron Artery Dis; 2018 Mar; 29(2):151-160. PubMed ID: 29120880
[TBL] [Abstract][Full Text] [Related]
14. Meta-Analysis Comparing Complete Revascularization Versus Infarct-Related Only Strategies for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease.
Shah R; Berzingi C; Mumtaz M; Jasper JB; Goswami R; Morsy MS; Ramanathan KB; Rao SV
Am J Cardiol; 2016 Nov; 118(10):1466-1472. PubMed ID: 27642115
[TBL] [Abstract][Full Text] [Related]
15. Complete or Culprit-Only Revascularization for Patients With Multivessel Coronary Artery Disease Undergoing Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis of Randomized Trials.
Elgendy IY; Mahmoud AN; Kumbhani DJ; Bhatt DL; Bavry AA
JACC Cardiovasc Interv; 2017 Feb; 10(4):315-324. PubMed ID: 28231899
[TBL] [Abstract][Full Text] [Related]
16. Complete Revascularization vs Culprit Lesion-Only Percutaneous Coronary Intervention for Angina-Related Quality of Life in Patients With ST-Segment Elevation Myocardial Infarction: Results From the COMPLETE Randomized Clinical Trial.
Mehta SR; Wang J; Wood DA; Spertus JA; Cohen DJ; Mehran R; Storey RF; Steg PG; Pinilla-Echeverri N; Sheth T; Bainey KR; Bangalore S; Cantor WJ; Faxon DP; Feldman LJ; Jolly SS; Kunadian V; Lavi S; Lopez-Sendon J; Madan M; Moreno R; Rao SV; Rodés-Cabau J; Stankovic G; Bangdiwala SI; Cairns JA;
JAMA Cardiol; 2022 Nov; 7(11):1091-1099. PubMed ID: 36129696
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis of Complete versus Culprit-Only Revascularization in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Disease.
Levett JY; Windle SB; Filion KB; Cabaussel J; Eisenberg MJ
Am J Cardiol; 2020 Nov; 135():40-49. PubMed ID: 32871112
[TBL] [Abstract][Full Text] [Related]
18. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
[TBL] [Abstract][Full Text] [Related]
19. Multivessel Versus Culprit Vessel-Only Percutaneous Coronary Intervention Among Patients With Acute Myocardial Infarction: Insights From the TRANSLATE-ACS Observational Study.
Ibrahim H; Sharma PK; Cohen DJ; Fonarow GC; Kaltenbach LA; Effron MB; Zettler ME; Peterson ED; Wang TY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982673
[TBL] [Abstract][Full Text] [Related]
20. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
